These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33080112)

  • 1. A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic.
    Hansel K; Zangrilli A; Bianchi L; Peris K; Chiricozzi A; Offidani A; Diotallevi F; Fargnoli MC; Esposito M; Amerio P; Gualdi G; Bianchi L; Stingeni L
    J Eur Acad Dermatol Venereol; 2021 Mar; 35(3):e169-e170. PubMed ID: 33080112
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of biologics for psoriasis patients during the COVID-19 pandemic: the experience from Wuhan, China.
    Zhao L; Du H; Alamgir M; Yang J; Miao X; Jiang B; Xia Y; Lou Y; Wang Y; Shen C; Zhu J; Chung WH; Li Y; Tao J
    Eur J Dermatol; 2020 Dec; 30(6):738-740. PubMed ID: 33459264
    [No Abstract]   [Full Text] [Related]  

  • 3. Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.
    Rob F; Hugo J; Tivadar S; Boháč P; Gkalpakiotis S; Vargová N; Arenbergerová M; Hercogová J
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e682-e684. PubMed ID: 32594549
    [No Abstract]   [Full Text] [Related]  

  • 4. Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II.
    Camela E; Fabbrocini G; Cinelli E; Lauro W; Megna M
    Dermatology; 2021; 237(1):13-14. PubMed ID: 33296899
    [No Abstract]   [Full Text] [Related]  

  • 5. SARS-CoV-2 infection in a patient with psoriasis treated with risankizumab.
    Huang C; Chen T
    Dermatol Online J; 2021 Apr; 27(4):. PubMed ID: 33999591
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers.
    Damiani G; Allocco F; ; Malagoli P
    Clin Exp Dermatol; 2021 Aug; 46(6):1106-1108. PubMed ID: 33666256
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic drugs during COVID-19 outbreak.
    Montesu MA; Biondi G; Sotgiu G; Sucato F; Satta R
    Int J Dermatol; 2020 Oct; 59(10):1293. PubMed ID: 32767379
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era.
    Galluzzo M; Tofani L; Bianchi L; Talamonti M
    Expert Opin Biol Ther; 2020 Aug; 20(8):829-830. PubMed ID: 32510244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of surgical working in an Italian neighborhood hospital during the COVID-19 pandemic.
    Bagnoli PF; Nehchiri F; Lucini M; Messina ME; Morlacchi A; Lenna G; Ferrante P
    Minerva Chir; 2020 Dec; 75(6):462-465. PubMed ID: 32773749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and Safety of Kidney Transplantation from Deceased Donors during the COVID-19 Pandemic: Insights from an Italian Academic Centre.
    Li Marzi V; Campi R; Pecoraro A; Peris A; Serni S
    Actas Urol Esp (Engl Ed); 2020 Dec; 44(10):708-712. PubMed ID: 33077290
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating multidrug-resistant psoriasis with brodalumab, apremilast, methotrexate and prednisone combination therapy in the COVID-19 pandemic.
    Armesto S; González Vela C; Sánchez J; Illaro A; Mayorga J; López Sundh AE; Naharro Fernández C; Palmou N; Gómez-Fernández C; González López MA; González-Gay MA
    Dermatol Ther; 2020 Nov; 33(6):e14464. PubMed ID: 33112014
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous manifestations in an Italian military COVID hub.
    Di Nunno D; Laghi A; Troiani G; Marseglia B; Anelli L; Farina E; Tarricone F; Mammana G; Catalano C; Bonito A; De Capua A; Caramanico G; Blasioli S; Astorino S
    G Ital Dermatol Venereol; 2020 Oct; 155(5):632-635. PubMed ID: 33295741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified.
    Ferrara F; Pianesi L; Vitiello A
    Immunol Res; 2021 Apr; 69(2):115-116. PubMed ID: 33860404
    [No Abstract]   [Full Text] [Related]  

  • 14. Parents' Perception of Food Insecurity and of Its Effects on Their Children in Italy Six Months after the COVID-19 Pandemic Outbreak.
    Dondi A; Candela E; Morigi F; Lenzi J; Pierantoni L; Lanari M
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].
    Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The preparedness of the Italian obstetric surveillance system in the response to the emergency of the SARS-CoV-2 pandemic: methodological aspects of a population-based study].
    Corsi E; Maraschini A; Perrone E; Salvatore MA; D'aloja P; Donati S;
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):81-87. PubMed ID: 33412797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 and the Use of Biologics in Patients With Psoriasis [Formula: see text].
    Ladda M; Lynde C; Fleming P
    J Cutan Med Surg; 2020; 24(6):625-632. PubMed ID: 32757760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance of psoriatic patients on biologic treatment during the COVID-19 pandemic: A single-center experience.
    Polat Ekinci A; Pehlivan G; Gökalp MO
    Dermatol Ther; 2021 Jan; 34(1):e14700. PubMed ID: 33369063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas.
    Michelucci A; Margiotta FM; Cartocci A; Panduri S; Trovato E; Calpalbo E; Dragotto M; Di Cesare A; Rosi E; Rossari S; Magnano M; Pescitelli L; Buggiani G; Simoni B; Lorenzoni E; Ricceri F; Savarese I; Milanesi N; Rubegni P; Prignano F; Romanelli M
    Arch Dermatol Res; 2024 May; 316(6):272. PubMed ID: 38796581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical factors conditioning the management of appendicitis in children during COVID-19 Pandemic: experience from the outbreak area of Lombardy, Italy.
    Raffaele A; Cervone A; Ruffoli M; Cereda E; Avolio L; Parigi GB; Riccipetitoni G
    Br J Surg; 2020 Oct; 107(11):e529-e530. PubMed ID: 32835410
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.